[1]
R. Adawiyah, S. ., and I. M. Artika, “HISTONE ACETYLTRANSFERASE P300/CBP-ASSOCIATED FACTOR INHIBITION BY QUERCETIN AS ANTICANCER DRUG CANDIDATE WITH IN SILICO AND IN VITRO APPROACH”, Int J Pharm Pharm Sci, vol. 8, no. 5, pp. 211–215, May 2016.